Buprenorphine and Naloxone
These highlights do not include all the information needed to use BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM safely and effectively. See full prescribing information for BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM. BUPRENORPHINE and NALOXONE sublingual film, for sublingual or buccal use, CIII.Initial U.S. Approval: 2002
4210afeb-474c-d842-d68e-af7e0021851a
HUMAN PRESCRIPTION DRUG LABEL
Jan 31, 2024
Alvogen Inc.
DUNS: 008057330
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Buprenorphine and Naloxone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
Buprenorphine and Naloxone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
Buprenorphine and Naloxone
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (17)
Buprenorphine and Naloxone
Product Details
FDA regulatory identification and product classification information